from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1325c/PE_PGRS24

LFCtreatmentdescriptionclass of inhibitor

2.321

Amikacinug/mL Amikacintranslation

1.960

Cap5-10ug/mL Capreomycintranslation

1.748

Rox10-50 ug/mL Roxithromycintranslation

0.641

SM2-5 ug/mL Streptomycintranslation

2.958

Tet5-10 ug/mL Tetracyclinetranslation

-1.062

Rif0.2-5ug/mL Rifampicintranscription

-0.799

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.799

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.035

CPZ10-50 ug/mL Chlorpromazinerespiration

1.147

Clofazimine10-13 ug/mL Clofaziminerespiration

0.113

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.537

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.373

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.256

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.421

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.533

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.106

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.359

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.742

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.139

KCN5-20 ug/mL Potassium cyaniderespiration

1.254

NaN30.2-2 mM Sodium aziderespiration

0.406

Nigericin50 uM Nigericinrespiration

-0.201

TRC10-150 ug/mL Triclosanrespiration

0.201

TRZ10-25 ug/mL Thioridazinerespiration

-1.478

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.632

menadione6-10 ug/mL Menadionerespiration

0.252

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.387

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.081

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.944

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.818

NRP_1Non-replicating persistence stage 1dosRassociated

-0.018

Amp0.2mg/mL AmpicillincellWall

0.048

Cephalexin20-100 ug/mL CephalexincellWall

-0.891

Cerulenin0.32-5 ug/mL CerulenincellWall

0.371

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.506

EMB10-20 ug/mL EthambutolcellWall

-0.618

Eta12-40 ug/mL EthionamidecellWall

0.059

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.685

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.134

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.200

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.047

BZA0.12 mg/mL BenzamidearomaticAmides

-0.011

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.497

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.459

H2O24 mM hydrogen peroxideDNAdamaging

-0.031

Levo10 ug/mL LevofloxacinDNAdamaging

-0.137

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.770

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.486

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.670

UVUV-irradiationDNAdamaging

-0.987

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.199

Antimycin12.5-50 ug/mL Antimycin A?

-0.768

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.490

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.496

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.339

PA8240.2-2 ug/mL PA-824?

0.870

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.073

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-1.036

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.401

methoxatin10-20 ug/mL Methoxatin?